Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bausch + Lomb Corporation (BLCO : NYSE)

• Company Description    Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. Number of Employees: 13,000

• Price / Volume Information    Yesterday's Closing Price: $16.17 Daily Weekly Monthly 20 Day Moving Average: 364,791 shares Shares Outstanding: 357.06 (millions) Market Capitalization: $5,773.61 (millions) Beta: 0.56 52 Week High: $18.92 52 Week Low: $13.09 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.63% 0.89% 12 Week 1.70% -1.09% Year To Date -5.33% -13.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 520 APPLEWOOD CRESCENT - VAUGHAN,A6 L4K 4B4 CAN ph: 905-695-7700 fax: - None http://www.bausch.com

• General Corporate Information    Officers Brenton L. Saunders - Chairman of the Board and Chief Executive Officer Sam Eldessouky - Executive Vice President and Chief Financial Offic Frederick J. Munsch - Senior Vice President; Controller and Chief Accoun Eduardo Alfonso - Director Nathalie Bernier - Director Peer Information Bausch + Lomb Corporation (CHCR) Bausch + Lomb Corporation (ESRX) Bausch + Lomb Corporation (MYDP) Bausch + Lomb Corporation (COR) Bausch + Lomb Corporation (GBCS) Bausch + Lomb Corporation (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 071705107 SIC: 3851 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 07/29/26 Share - Related Items Shares Outstanding: 357.06 Most Recent Split Date: (:1) Beta: 0.56 Market Capitalization: $5,773.61 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.82 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 39.42% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/29/26

• Fundamental Ratios P/E Current FY Estimate: 19.66 Trailing 12 Months: 24.88 PEG Ratio: 0.50 Price Ratios Price/Book: 0.89 Price/Cash Flow: 9.69 Price / Sales: 1.11 EPS Growth vs. Year Ago Period: 214.29% vs. Previous Quarter: -75.00% Sales Growth vs. Year Ago Period: 9.41% vs. Previous Quarter: -11.46% ROE 06/30/26 - - 03/31/26 - 3.60 12/31/25 - 2.77 ROA 06/30/26 - - 03/31/26 - 1.69 12/31/25 - 1.31 Current Ratio 06/30/26 - - 03/31/26 - 1.53 12/31/25 - 1.55 Quick Ratio 06/30/26 - - 03/31/26 - 0.99 12/31/25 - 1.04 Operating Margin 06/30/26 - - 03/31/26 - 4.49 12/31/25 - 3.53 Net Margin 06/30/26 - - 03/31/26 - -4.21 12/31/25 - -7.06 Pre-Tax Margin 06/30/26 - - 03/31/26 - -3.86 12/31/25 - -6.21 Book Value 06/30/26 - - 03/31/26 - 18.10 12/31/25 - 18.40 Inventory Turnover 06/30/26 - - 03/31/26 - 2.05 12/31/25 - 2.02 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.78 12/31/25 - 0.77 Debt-to-Capital 06/30/26 - - 03/31/26 - 43.81 12/31/25 - 43.62

Powered by Zacks Investment Research ©